{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T10:37:35Z","timestamp":1756809455618},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CPD"],"published-print":{"date-parts":[[2004,7,1]]},"DOI":"10.2174\/1381612043384114","type":"journal-article","created":{"date-parts":[[2005,3,18]],"date-time":"2005-03-18T04:27:07Z","timestamp":1111120027000},"page":"2249-2261","source":"Crossref","is-referenced-by-count":15,"title":["Treatment of Patients with Schizophrenia and Substance Abuse Disorders"],"prefix":"10.2174","volume":"10","author":[{"given":"John","family":"Tsuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Fong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/62910","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T14:30:29Z","timestamp":1448029829000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1381-6128&volume=10&issue=18&spage=2249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,1]]},"references-count":0,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2004,7,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612043384114","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7,1]]}}}